In 1,801 patients in the 1985-1986 Percutaneous Transluminal Coronary Angioplasty Registry, overall 1-year mortality was 3.2%, the 1-year myocardial infarction rate was 7.2%, and the l-year coronary artery bypass surgery rate was 13.2%. In the 78% of the cohort with all lesions successfully dilated and without major procedural complications (successful patients), the corresponding rates were 1....

Percutaneous transluminal coronary angioplasty (PTCA) or balloon angioplasty, was performed in the United States, but the technique remained challenged by the primary problem of ''re-stenosis'', which was approximately 30% closing of the coronary artery after balloon dilatation. When first PTCA introduced by Gruentzig in 1977, it was specific directed for patients who have angina, documented is...

T he worse long term outcome observed after percutaneous transluminal coronary angioplasty (PTCA) than after coronary artery bypass grafting (CABG) in patients at high risk of restenosis and disease progression such as diabetics, remind us that there is a substantial difference between treating a focal lesion with percutaneous coronary intervention and the use of arterial or vein grafts which b...

Significant unprotected left main coronary artery (ULMCA) disease occurs in 5-7% of patients undergoing coronary angiography [1,2] and patients with ULMCA disease treated medically have a three years mortality rate of 50% [3,4]. Advances in percutaneous intervention techniques and stent technology have allowed evolution of the role of percutaneous coronary intervention (PCI) for left main disea...

Coronary artery dissection is a common occurrence after percutaneous transluminal coronary angioplasty (PTCA). However, we report herein a rare case of double-barrel coronary artery dissection occurring 1 year after PTCA for stenosis in the left circumflex coronary artery. The case history and angiographic findings are reported, and relevant literature is reviewed.

There is controversy regarding the application of angioplasty to patients with multivessel disease in whom all significant stenoses are not dilated. We analyzed the outcomes of 286 patients with multivessel disease and prior successful angioplasty at a mean follow-up duration of 26.2 months. End points analyzed included death, myocardial infarction, late revascularization, and angina pectoris. ...

Gruentzig A: Transluminal dilatation of coronary artery stenosis. Lancet 1: 263, 1978 Kent KM, Bentiusglio LG, Block PC, et al: Percutaneous transluminal coronary angioplasty: report from the NHLBI registry. Am J Cardiol 49: 2011-2020, 1982 Doros G, Cowley MI, Simpson J, et al: Percutaneous transluminal coronary angioplasty report of complications from the National Heart Lung and Blood Institut...